Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2012 1
2013 1
2014 1
2015 1
2018 2
2019 3
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "FIGO Stage II Gestational Trophoblastic Tumor"
Page 1
Update on the diagnosis and management of gestational trophoblastic disease.
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L. Ngan HYS, et al. Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:79-85. doi: 10.1002/ijgo.12615. Int J Gynaecol Obstet. 2018. PMID: 30306586
Gestational trophoblastic disease (GTD) arises from abnormal placenta and is composed of a spectrum of premalignant to malignant disorders. ...High-risk GTN (FIGO Stages II-III: score >7 and Stage IV) is treated with multiple ag …
Gestational trophoblastic disease (GTD) arises from abnormal placenta and is composed of a spectrum of premalignant to …
Gestational trophoblastic neoplasia: experience at Salah Azaiez Institute.
Batti R, Mokrani A, Rachdi H, Raies H, Touhami O, Ayadi M, Meddeb K, Letaief F, Yahiaoui Y, Chraiet N, Mezlini A. Batti R, et al. Pan Afr Med J. 2019 Jun 17;33:121. doi: 10.11604/pamj.2019.33.121.13897. eCollection 2019. Pan Afr Med J. 2019. PMID: 31489099 Free PMC article.
Gestational trophoblastic disease (GTD) develops from abnormal cellular proliferation of trophoblasts following fertilization. It includes benign trophoblastic disease (hydatidiform moles (HM)) and the malignant trophoblastic diseases or …
Gestational trophoblastic disease (GTD) develops from abnormal cellular proliferation of trophoblasts following fertili …
Placental site trophoblastic tumor: analysis of presentation, treatment, and outcome.
Hyman DM, Bakios L, Gualtiere G, Carr C, Grisham RN, Makker V, Sonoda Y, Aghajanian C, Jewell EL. Hyman DM, et al. Gynecol Oncol. 2013 Apr;129(1):58-62. doi: 10.1016/j.ygyno.2012.12.029. Epub 2012 Dec 26. Gynecol Oncol. 2013. PMID: 23274560
OBJECTIVE: Placental-site trophoblastic tumor (PSTT) is the rarest form of gestational trophoblastic disease (GTD). ...RESULTS: Data from 17 patients were analyzed. Eight (47%) had Stage I/II disease and 9 (53%) had Stage …
OBJECTIVE: Placental-site trophoblastic tumor (PSTT) is the rarest form of gestational trophoblastic disease …
Results of treatment of gestational trophoblastic neoplasia in the Slovak Republic in the years 1993-2017.
Korbeľ Miroslav, Šufliarsky Jozef, Danihel Ľudovít, Nižňanská Zuzana. Korbeľ Miroslav, et al. Ceska Gynekol. 2021;86(2):94-101. doi: 10.48095/cccg202194. Ceska Gynekol. 2021. PMID: 34020555 English.
METHODS: Retrospective analysis results of gestational trophoblastic neoplasia treatment in the Centre for gestational trophoblastic disease in the Slovak Republic in Bratislava in the years 1993-2017 according to prognostic scoring and …
METHODS: Retrospective analysis results of gestational trophoblastic neoplasia treatment in the Centre for gestational …
Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial.
You B, Bolze PA, Lotz JP, Massardier J, Gladieff L, Joly F, Hajri T, Maucort-Boulch D, Bin S, Rousset P, Devouassoux-Shisheboran M, Roux A, Alves-Ferreira M, Grazziotin-Soares D, Langlois-Jacques C, Mercier C, Villeneuve L, Freyer G, Golfier F. You B, et al. J Clin Oncol. 2020 Sep 20;38(27):3129-3137. doi: 10.1200/JCO.20.00803. Epub 2020 Jul 27. J Clin Oncol. 2020. PMID: 32716740 Free PMC article. Clinical Trial.
RESULTS: Between December 2016 and September 2018, 15 patients were treated. Median age was 34 years; disease stage was I or III in 53.3% and 46.7% of women, respectively; and International Federation of Gynecology and Obstetrics (FIGO) score was 0-4 in 33.3% …
RESULTS: Between December 2016 and September 2018, 15 patients were treated. Median age was 34 years; disease stage was I or I …
The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia.
Frijstein MM, Lok CAR, Short D, Singh K, Fisher RA, Hancock BW, Tidy JA, Sarwar N, Kanfer E, Winter MC, Savage PM, Seckl MJ. Frijstein MM, et al. Eur J Cancer. 2019 Mar;109:162-171. doi: 10.1016/j.ejca.2018.12.033. Epub 2019 Feb 4. Eur J Cancer. 2019. PMID: 30731277
OBJECTIVE: The objective of the study was to evaluate the effect of high-dose chemotherapy (HDC) with peripheral blood stem cell support (PBSCS) on survival of patients with gestational trophoblastic neoplasia (GTN) with either refractory choriocarcinomas or a poor- …
OBJECTIVE: The objective of the study was to evaluate the effect of high-dose chemotherapy (HDC) with peripheral blood stem cell support (PB …
Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database.
Frijstein MM, Lok CAR, van Trommel NE, Ten Kate-Booij MJ, Massuger LFAG, van Werkhoven E, Kaur B, Tidy JA, Sarwar N, Golfier F, Winter MC, Hancock BW, Seckl MJ; all the contributors to the ISSTD PSTT/ETT database. Frijstein MM, et al. Gynecol Oncol. 2019 Feb;152(2):361-367. doi: 10.1016/j.ygyno.2018.11.015. Epub 2018 Nov 22. Gynecol Oncol. 2019. PMID: 30473257
Thirty-six patients had FIGO stage I and 18 had stages II-IV disease. Patients were treated with surgery (n = 23), chemotherapy (n = 6), or a combination of surgery and chemotherapy (n = 25). ...Patients treated with surgery as first line treatm …
Thirty-six patients had FIGO stage I and 18 had stages II-IV disease. Patients were treated with surgery …
Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Al-Husaini H, Soudy H, Darwish A, Ahmed M, Eltigani A, Edesa W, Elhassan T, Omar A, Elghamry W, Al-Hashem H, Al-Hayli S, Madkhali I, Ahmad S, Al-Badawi IA. Al-Husaini H, et al. Clin Transl Oncol. 2015 May;17(5):409-15. doi: 10.1007/s12094-014-1251-1. Epub 2014 Nov 15. Clin Transl Oncol. 2015. PMID: 25398721
PURPOSE: To report the outcomes of gestational trophoblastic neoplasia (GTN) at a single institution and to determine the factors affecting response to chemotherapy and survival. ...OS was significantly influenced by the type of antecedent pregnancy (molar 98 % vs. …
PURPOSE: To report the outcomes of gestational trophoblastic neoplasia (GTN) at a single institution and to determine the fact …
Vaginal metastases in gestational trophoblastic neoplasia.
Berry E, Hagopian GS, Lurain JR. Berry E, et al. J Reprod Med. 2008 Jul;53(7):487-92. J Reprod Med. 2008. PMID: 18720923
OBJECTIVE: To evaluate the clinical experience and outcomes of patients with gestational trophoblastic neoplasia (GTN) complicated by vaginal metastases. ...FIGO stage was II in 13 patients (36%), III in 22 patients (61%) and IV in 1 patient (3% …
OBJECTIVE: To evaluate the clinical experience and outcomes of patients with gestational trophoblastic neoplasia (GTN) complic …
Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trial.
You B, Bolze PA, Lotz JP, Massardier J, Gladieff L, Floquet A, Hajri T, Descargues P, Langlois-Jacques C, Bin S, Villeneuve L, Roux A, Alves-Ferreira M, Grazziotin-Soares D, Dherret G, Gerentet C, Rousset P, Freyer G, Golfier F. You B, et al. Gynecol Oncol. 2023 Jan;168:62-67. doi: 10.1016/j.ygyno.2022.11.005. Epub 2022 Nov 16. Gynecol Oncol. 2023. PMID: 36401942 Clinical Trial.
PURPOSE: There is a need for innovative treatments in women with gestational trophoblastic tumors (GTT) resistant to chemotherapy. The TROPHIMMUN trial assessed the efficacy of avelumab in patients with resistance to single-agent chemotherapy (cohort A), or to polyc …
PURPOSE: There is a need for innovative treatments in women with gestational trophoblastic tumors (GTT) resistant to chemother …